StayHappi Pharmacy: Quality Medicines at ‘Real and Affordable’ price for patients. StayHappi Pharmacy is an initiative of Sarva Gun Aushdhi Private Limited has been incepted in October 2017 with a firm belief to serve humanity by providing High-Quality Medicines at ‘Real and Affordable’ price. It provides medicines with their molecule name and not by the brand name, where patients will have the power to choose the right medicine and make a smart choice. StayHappi Stores have medicines ranging from Allopathic, Ayurvedic or Herbal & Nutraceuticals, OTC or Consumables and Cosmetics as well as Surgical Items & Medical Devices that comprises of Antibiotics, Cough & Cold Preparations, Paediatrics, Anti-Hypertensives, Pain Management, Pre & Probiotics, Anti-amoebic, Geriatric Care, Dermatological, CVS & Dyslipidaemia, Respiratory, Ophthalmic, Hormones Gastrointestinal Tract (GIT), Antiepileptic, CNS, Urological, Anti-diabetics, Antipyretics, Gynaecology and Sedatives / Hypnotics.
The partners manufacture about 15% of the country’s total medicinal consumption and maintain the highest standards of quality. Their facilities are regularly audited and approved for manufacturing by regulating authorities like the US FDA, WHO GMP, USNSF, NABL, PICS, ISO 9001-2008, and ISO 14001-2015. StayHappi is delighted to partner with retail outlets/sub-franchisee, development partners and other associations for increased access to medicines for everyone.
The company has a central warehouse and a robust supply chain with a distribution network across all states in the country. The aim is to create employment opportunities for thousands of pharmacists, doctors, and business opportunities for entrepreneurs. StayHappi team has over 30 years of experience in the pharmaceutical industry from manufacturing, supply chain, distribution and marketing.
StayHappi plans to scale up and reach every nook and corner in the country and to make “Health for all” a reality. Initially, the company is looking to scale up to 1,000 retail pharmacy stores by 2020 and will launch 1,000 products in a phased manner. Subsequently, the company will increase the product mix that would offer a comprehensive range of products covering all types of therapeutic form, dosage forms, consumables and healthcare products.
